Audit Reports
51 - 60 of 405 Results
Audit Reports
SAFETY AND SECURITY: The Company Has Made Significant Progress Implementing New Safety Program
Our objective for this report was to assess the extent to which the company is incorporating its injury claims financial data into its Safety Management System (SMS).
Tracking Number: OIG-A-2021-008 | 04/08/2021
Audit Reports
Safety and Security: The Company Can More Effectively Use Injury Claims Data to Help Reduce Risks
Our objective for this report was to assess the extent to which the company is incorporating its injury claims financial data into its Safety Management System (SMS).
Tracking Number: OIG-A-2021-007 | 02/25/2021
Audit Reports
GOVERNANCE: Quality Control Review of the Independent Audit of Amtrak’s Consolidated Financial Statements for Fiscal Year Ended 2020
Amtrak (the company) contracted with the independent certified public accounting firm of Ernst & Young LLP to audit its consolidated financial statements as of September 30, 2020, and for the year then ended, and to provide a report on interna
Tracking Number: OIG-A-2021-006 | 12/23/2020
Audit Reports
GOVERNANCE: Final Observations on Amtrak’s Use of CARES Act Funds
Our objective for this report was to complete our review of the company’s use of Coronavirus Aid, Relief, and Economic Security (CARES) Act funds and its controls to accurately track and report on them.
Tracking Number: OIG-A-2021-005 | 12/15/2020
Audit Reports
SAFETY AND SECURITY: Amtrak Expects Positive Train Control will be Interoperable with Other Railroads but Could Better Measure System Reliability
Our objective for this report was to assess the extent to which the company’s systems are interoperable with its hosts and tenants, and the compa
Tracking Number: OIG-A-2021-004 | 12/11/2020
Audit Reports
SAFETY AND SECURITY: Expanded Random Drug Testing Could Help Further Detect and Deter Prescription Opioid Misuse
Our objectives for this report were to assess (1) the extent to which the company’s employees who perform safety-related work are at risk for prescription opioid impairment and misuse and (2) the company’s efforts to detect and deter this risk.
Tracking Number: OIG-A-2021-003 | 10/27/2020
